5.22
Cholinerge Antagonisten: Therapeutische Anwendungen
Antimuskarinische Medikamente haben verschiedene therapeutische Anwendungen, indem sie die parasympathische Stimulation in verschiedenen Systemen hemm…
Es sei daran erinnert, dass Antimuskarinika den parasympathischen Abfluss hemmen und somit bei der Behandlung verschiedener Pathologien der innervierten Organe nützlich sind.
Ihre ZNS-Wirkung beugt der Reisekrankheit vor.
Bei der Parkinson-Krankheit werden die neurologischen Wirkungen von Antimuskarinika zur Behandlung von Sialorrhö und Zittern eingesetzt.
Für die Untersuchung des Auges sind ihre mydriatischen und zykloplegischen Wirkungen von Vorteil. Durch die Linderung von Krämpfen und die Entspannung der Augeninnenmuskulatur helfen sie bei der Behandlung von Augenerkrankungen.
Als Bronchodilatatoren können Antimuskarinika Asthma, Bronchitis und chronisch obstruktive Lungenerkrankungen behandeln.
Bei kardiovaskulären Ereignissen wie Myokardinfarkt können Antimuskarinika bei der Behandlung von Bradykardie und partiellem Herzblock helfen.
Ihre krampflösende Wirkung entspannt die glatte Muskulatur des Darms. Daher sind sie nützlich bei der Behandlung des entzündlichen Darmsyndroms oder bei endoskopischen Eingriffen.
Sie sind auch wirksam bei der Behandlung einer überaktiven Blase.
Antimuskarinika, die vor der Intubation verabreicht werden, sind nützlich bei der Vorbeugung von Laryngospasmus .
Schließlich dienen Antimuskarinika als Gegenmittel bei Vergiftungen mit Anticholinesterase-Organophosphor.
View the full transcript and gain access to JoVE Core videos
Q1: How do antimuscarinics treat respiratory conditions like asthma and COPD?
Antimuscarinics such as ipratropium, aclidinium, and tiotropium act as bronchodilators by relaxing airway smooth muscles and reducing bronchoconstriction. They protect against airway constriction caused by irritants like cigarette smoke and ozone, making them effective for treating asthma, chronic bronchitis, and COPD. They also reduce nasopharyngeal secretions in rhinorrhea and allergic rhinitis.
Q2: What role do antimuscarinics play in managing Parkinson's disease symptoms?
Antimuscarinics like benzhexol, trihexyphenidyl, and benztropine suppress cholinergic neurotransmission in the basal ganglia, reducing tremors and rigidity associated with Parkinson's disease. They also control sialorrhea, or excessive salivation, a common symptom. These agents are similarly used to manage antipsychotic-induced extrapyramidal side effects.
Q3: Why are antimuscarinics useful during eye examinations and ocular procedures?
Antimuscarinics like homatropine, cyclopentolate, and tropicamide produce mydriatic and cycloplegic effects when applied topically to the eye. Mydriasis dilates the pupil for better visualization during examination, while cycloplegia relaxes the ciliary muscle, preventing accommodation. These effects enable comprehensive ocular assessment and treatment of various eye conditions.
Q4: How do antimuscarinics help treat gastrointestinal disorders?
Antimuscarinics relax gastrointestinal smooth muscles through their antispasmodic action, making them valuable for treating inflammatory bowel syndrome, irritable bowel syndrome, and functional diarrhea. Agents like hyoscine and scopolamine aid endoscopy and gastrointestinal radiology procedures. Pirenzepine is preferred for peptic ulcers due to its receptor specificity.
Q5: What is the mechanism by which antimuscarinics treat overactive bladder?
Antimuscarinics such as oxybutynin, tolterodine, trospium, darifenacin, solifenacin, and fesoterodine inhibit parasympathetic stimulation of bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity. This relaxation decreases urinary frequency, effectively treating overactive bladder and enuresis in children with improved symptom control.
Q6: How do antimuscarinics function as antidotes in organophosphorus poisoning?
Antimuscarinics serve as antidotes for organophosphorus insecticide poisoning by blocking muscarinic receptors and counteracting excessive acetylcholine accumulation. This prevents cholinergic overstimulation and its toxic effects. Understanding anticholinesterase agents poisoning and treatment is essential for recognizing how antimuscarinics reverse poisoning symptoms.
Q7: Why do selective antimuscarinics have better patient compliance than non-selective agents?
Non-selective antimuscarinics block receptors across multiple organs, causing widespread undesirable side effects that reduce long-term patient compliance. Selective agents with receptor or organ specificity target particular tissues, minimizing adverse effects while maintaining therapeutic benefits. This targeted approach improves patient adherence and treatment outcomes.